Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Repligen Corp (NASDAQ:RGEN)

40.21
Delayed Data
As of Aug 18
 +0.50 / +1.26%
Today’s Change
26.16
Today|||52-Week Range
46.81
+30.47%
Year-to-Date

Today’s Trading

Previous close39.71
Today’s open39.42
Day’s range39.34 - 40.48
Volume266,076
Average volume (3 months)324,263
Market cap$1.5B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+21.43%
Earnings growth (this year)+34.47%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+25.14%
P/E ratio78.8
Price/Sales10.05
Price/Book8.06

Competitors

 Today’s
change
Today’s
% change
ARRYArray Biopharma Inc-0.01-0.11%
LXRXLexicon Pharmaceutic...-0.35-2.44%
TBPHTheravance Biopharma...-0.26-0.94%
PCRXPacira Pharmaceutica...-0.25-0.69%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$0.11
Annual revenue (last year)$104.5M
Annual profit (last year)$11.7M
Net profit margin11.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts